Fateme Babaha: Pleasure to Present A Novel FVIII Gene Therapy Enhancer at ISTH 2026
Fateme Babaha, PhD in Pathology and Molecular Medicine at Queen’s University, shared on LinkedIn:
”It was a pleasure to present my research at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris!
It had the opportunity to present my work, ‘Efficacy of AAV-mediated FVIII transgene expression employing a short enhancer element from the human F8 locus,’ and to connect with researchers and experts in the field of hemophilia and gene therapy.
In this study, we investigated a novel, compact 92-bp enhancer element from the human F8 locus and its potential to improve FVIII transgene expression for hemophilia A gene therapy.
I’m grateful to my supervisor Dr. David Lillicrap for his continued support and to everyone who stopped by my poster for the insightful discussions and questions.”
Stay updated with Hemostasis Today.
-
Jul 24, 2026, 05:04Moustafa Abdou: Unmasking Pure Red Cell Aplasia
-
Jul 24, 2026, 04:53Ana Pedrero Gil: The Future of Blood-Derived Therapies
-
Jul 24, 2026, 04:50Marc Wittwer: How We’re Making Hemostasis Diagnostics Faster, Simpler, and More Ergonomic
-
Jul 24, 2026, 04:41Akshat Jain: Reassessing Cost-Effectiveness of Iron Deficiency Anemia Treatments
-
Jul 24, 2026, 04:36Mehari Gebreyohanns: The Official Event Page for ASOC 2026 Is Now Live
-
Jul 24, 2026, 03:57Balvinder Bobbie Saarsalu: Hemostatic Biomarkers in Acute Myeloid Leukemia
-
Jul 24, 2026, 03:44Manabu Inoue: Tenecteplase or Alteplase Before Thrombectomy by T-FLAVOR Trial
-
Jul 24, 2026, 03:36We Received The AHA Get With The Guidelines Stroke Gold Plus Quality Achievement Award – Lakeland Regional Health-Florida
-
Jul 24, 2026, 03:31Ana Catarina Fonseca: The Persistent Gaps in Blood Pressure Guideline Achievement After Stroke